TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Concentration required to reduce binding of human 293 cell attachment to immobilized vitronectin receptor(Vn/293) by 50%More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)